| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/30/1998 | WO1998032430A1 Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 07/30/1998 | WO1998032425A1 Pharmaceutical formulations with delayed drug release |
| 07/30/1998 | WO1998032421A1 Ophthalmic compositions including glycerin and propylene glycol |
| 07/30/1998 | WO1998024478A3 Tumour therapy |
| 07/30/1998 | WO1998023286A3 Immunoconjugates comprising human monoclonal antibodies or fragments thereof for diagnostic and therapy |
| 07/30/1998 | WO1998022508A3 Process for tumour cell depletion of cd34-positive cells |
| 07/30/1998 | WO1998019709A3 Cationic reagents for transfection |
| 07/30/1998 | WO1998018501A3 Improvements in or relating to diagnostic/therapeutic agents |
| 07/30/1998 | WO1998018495A3 Improvements in or relating to diagnostic/therapeutic agents |
| 07/30/1998 | WO1998014168A3 Dosage form providing a sustained and ascending drug release |
| 07/30/1998 | CA2626424A1 Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 07/30/1998 | CA2278924A1 Method and conjugate for treating h. pylori infection |
| 07/30/1998 | CA2278663A1 Urease-responsive delivery systems for diagnostic and therapeutic applications |
| 07/30/1998 | CA2277970A1 Composition for the transdermal administration of steroid drugs |
| 07/30/1998 | CA2228017A1 A drug preparation for oral administration |
| 07/29/1998 | EP0855185A2 Host-vector system for use in gene therapy |
| 07/29/1998 | EP0855183A2 Manufacture of taste-masked preparations of antibacterial quinolone derivatives |
| 07/29/1998 | EP0854930A1 Pharmaceutical composition useful for nucleic acid transfection, and use thereof |
| 07/29/1998 | EP0854929A1 Recombinant viruses incorporating a protease cleavable protein |
| 07/29/1998 | EP0854925A1 THE NucA PROTEIN OF $i(HAEMOPHILUS INFLUENZAE) AND THE GENE ENCODING THAT PROTEIN |
| 07/29/1998 | EP0854731A1 Copolymeric micelle drug composition and method for the preparation thereof |
| 07/29/1998 | EP0854726A2 Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions |
| 07/29/1998 | EP0854718A2 Novel composition containing an acid-labile benzimidazole and process for its preparation |
| 07/29/1998 | EP0854707A1 Solid medicaments obtained by extrusion of an isomalt-containing polymer-active substance melt |
| 07/29/1998 | EP0854706A1 Method for synthesizing microcapsules of predetermined permeability |
| 07/29/1998 | EP0727982A4 Propylene glycol stearate vesicles |
| 07/29/1998 | EP0724437A4 Anthelmintic formulations |
| 07/29/1998 | EP0578774B1 Monoclonal antibodies to stem cell factor receptors |
| 07/29/1998 | CN1189105A Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagenosis |
| 07/29/1998 | CN1189100A Composition comprising amoxycillin and clavulanic acid |
| 07/29/1998 | CN1189098A Pharmaceutical composition stablilized with basic agent |
| 07/29/1998 | CN1189096A New stable medicinal compositions for generating propellant-free aerosols |
| 07/29/1998 | CN1188646A Preparation of concealed taste preparations of antibucterially active quinlone derivatives |
| 07/29/1998 | CN1188644A TPA injecta and its producing technology |
| 07/29/1998 | CN1188642A High-polymer encapsulated insulin microsome and its preparation method and use |
| 07/29/1998 | CN1039319C Method for preparing compound of pleuromutilin derivative and cyclodextrin |
| 07/29/1998 | CN1039284C Composition for treating pain and reinforcing pain relief action |
| 07/28/1998 | US5786512 Hydroxyhexyl disulfides |
| 07/28/1998 | US5786457 Hormone-nuclease compounds and method for regulating hormone related diseases |
| 07/28/1998 | US5786456 Bp 50-specific antibodies and fragments thereof |
| 07/28/1998 | US5786421 Method of preventing formation of adhesions following surgery |
| 07/28/1998 | US5786387 Lipid double-chain derivative containing polyoxyethylene |
| 07/28/1998 | US5786363 Aqueous compositions containing ciprofloxacine, and related use |
| 07/28/1998 | US5786322 Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 |
| 07/28/1998 | US5786155 Methods for identifying a compound that binds to a human 5-HT 1E receptor |
| 07/28/1998 | US5785993 Reduction of adhesions using controlled delivery of active oxygen inhibitors |
| 07/28/1998 | US5785991 Transdermal drug delivery |
| 07/28/1998 | US5785984 Taste-modifying method and bitterness-decreasing method |
| 07/28/1998 | US5785977 A stable dispersant in a liquid carrier for drug or cosmetic uses |
| 07/28/1998 | US5785973 Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines |
| 07/28/1998 | US5785969 Attaching hydrophobic chains to antibodies in the presence of surface active agents, removing surface active agents, allowing antibodies with attached chains to form micelle-like antibody aggregates |
| 07/28/1998 | US5785957 Inclusion of tooth whitening oxidation chemistries into a tooth-paste composition |
| 07/28/1998 | US5785950 Perfluorobis(chlorobutyl ether; medical imaging |
| 07/24/1998 | CA2227314A1 Preparation of concealed taste preparations of antibacterially active quinolone derivatives |
| 07/23/1998 | WO1998031739A1 A process for preparing polymeric microgels |
| 07/23/1998 | WO1998031712A2 Chitosan-conjugates with acidic chelate-complex forming agents |
| 07/23/1998 | WO1998031699A1 Crystal form 0 of clarithromycin |
| 07/23/1998 | WO1998031394A2 Tissue factor methods and compositions for coagulation and tumor treatment |
| 07/23/1998 | WO1998031393A2 Polysaccharide-peptide-conjugates |
| 07/23/1998 | WO1998031392A1 Nephrotropic drugs |
| 07/23/1998 | WO1998031391A1 Obesity protein formulations |
| 07/23/1998 | WO1998031390A1 Obesity protein formulations |
| 07/23/1998 | WO1998031386A1 Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method |
| 07/23/1998 | WO1998031361A1 Pharmaceutical composition of fenofibrate with high biological availability and method for preparing same |
| 07/23/1998 | WO1998031349A1 Transdermal, hormone-delivering therapeutic system |
| 07/23/1998 | WO1998031348A1 Transdermal, acetylsalicylic acid-containing therapeutic system with reinforced resorption |
| 07/23/1998 | WO1998031347A1 Production of new polymer liquid crystals capable of having an interaction with liposomes |
| 07/23/1998 | WO1998031346A1 Preparation of particles for inhalation |
| 07/23/1998 | WO1998031344A1 Taste masking for unpalatable formulations |
| 07/23/1998 | WO1998031343A2 Aqueous suspension for nasal administration of loteprednol |
| 07/23/1998 | WO1998025642A3 Pharmaceutical formulations comprising a water-insoluble complex for sustained drug delivery |
| 07/23/1998 | WO1998020869A3 Formulation for electrically assisted delivery of lidocaine and epinephrine |
| 07/23/1998 | WO1998018500A3 Improvements in or relating to diagnostic/therapeutic agents |
| 07/23/1998 | WO1998018493A3 Conjugates useful in the treatment of prostate cancer |
| 07/23/1998 | DE19702092A1 Use of 1,2-alkan-di:ol derivatives as thickeners |
| 07/23/1998 | CA2419499A1 Crystal form 0 of clarithromycin |
| 07/23/1998 | CA2278567A1 Production of new polymer liquid crystals capable of having an interaction with liposomes |
| 07/23/1998 | CA2278199A1 Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method |
| 07/23/1998 | CA2277831A1 Taste masking for unpalatable formulations |
| 07/23/1998 | CA2277366A1 Transdermal, acetylsalicylic acid-containing therapeutic system with reinforced resorption |
| 07/23/1998 | CA2277282A1 Obesity protein formulations |
| 07/23/1998 | CA2276427A1 Obesity protein formulations |
| 07/22/1998 | EP0853947A1 Matrix material comprising several bio-active materials |
| 07/22/1998 | EP0853945A1 Liquid gonadotropin containing formulations |
| 07/22/1998 | EP0853623A1 Enediyne compounds |
| 07/22/1998 | EP0853494A1 Oil-water emulsifiers |
| 07/22/1998 | EP0853483A1 Novel peptides |
| 07/22/1998 | EP0853476A2 Pharmaceutical preparation containing nimesulide for topical use |
| 07/22/1998 | EP0853474A2 Chemo-mechanical expansion delivery system |
| 07/22/1998 | EP0794767B1 Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams |
| 07/22/1998 | EP0620743B1 Contrast agents consisting of galactose particles and an amphiphilic carboxylic acid |
| 07/22/1998 | EP0610502B1 Emulsion containing parathyroid hormone for pernasal administration |
| 07/22/1998 | EP0608322B1 Enhanced skin penetration system for improved topical delivery of drugs |
| 07/22/1998 | EP0575613B1 Use of the amino acid glycine for the preparation of a medicament with antistress-, stress-preventive and nootropic action |
| 07/22/1998 | EP0444157B1 Collagen-polymer conjugates |
| 07/22/1998 | EP0415999B1 Compositions having use as treatment of psoriasis and neuropsychiatric deficits |
| 07/22/1998 | CN1188414A Novel formulation for peptide release |
| 07/22/1998 | CN1188413A Pharmaceutical and diet formulations for prophylaxis and treatment of gastrointestinal disorders |
| 07/22/1998 | CN1188408A Novel 'burst-free' sustained release poly-(lactide/glycolide) mi crospheres |
| 07/22/1998 | CN1188407A New pharmaceutical composition with anaesthetic effect |